Identification of Protective Lassa Virus Epitopes That Are Restricted by Hla-a2.
From: Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037, USA. jbotten@scripps.edu
Journal of virology
- Publish Date: Sep 2006
- ISSN: 0022-538X
- Volume: 80
- Issue: 17
- Pages: 8351-61
- Medium: Print
- Language: English
- Citation (JAMA): Botten Jason, Alexander Jeff, Pasquetto Valerie, et al. Identification of Protective Lassa Virus Epitopes That Are Restricted by Hla-a2.. J. Virol. Sep 2006;80:8351-61
Abstract
Recovery from Lassa virus (LASV) infection usually precedes the appearance of neutralizing antibodies, indicating that cellular immunity plays a primary role in viral clearance. To date, the role of LASV-specific CD8(+) T cells has not been evaluated in humans. To facilitate such studies, we utilized a predictive algorithm to identify candidate HLA-A2 supertype epitopes from the LASV nucleoprotein and glycoprotein precursor (GPC) genes. We identified three peptides (GPC(42-50), GLVGLVTFL; GPC(60-68), SLYKGVYEL; and GPC(441-449), YLISIFLHL) that displayed high-affinity binding (< or =98 nM) to HLA-A*0201, induced CD8(+) T-cell responses of high functional avidity in HLA-A*0201 transgenic mice, and were naturally processed from native LASV GPC in human HLA-A*0201-positive target cells. HLA-A*0201 mice immunized with either GPC(42-50) or GPC(60-68) were protected against challenge with a recombinant vaccinia virus that expressed LASV GPC. The epitopes identified in this study represent potential diagnostic reagents and candidates for inclusion in epitope-based vaccine constructs. Our approach is applicable to any pathogen with existing sequence data, does not require manipulation of the actual pathogen or access to immune human donors, and should therefore be generally applicable to category A through C agents and other emerging pathogens.
Mesh Headings (Keywords): Amino Acid Sequence, Animals, CD8-Positive T-Lymphocytes, Epitope Mapping, Epitopes, T-Lymphocyte, HLA-A2 Antigen, Humans, Immunization, Lassa Fever, Lassa virus, Mice, Mice, Transgenic, Molecular Sequence Data, Nucleocapsid Proteins, Peptides, Viral Envelope Proteins, Viral Vaccines
Check for Full Text / PubMed Unique Identifier (PMID): 16912286
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.